Newsletter Archive

1. 04.15.21 -- Generating A Fully Processed Antibody 4/15/2021
   04/15/21 BioProcess Online Newsletter
2. 04.14.21 -- How To Commercially Scale T-Cell Allogeneic Therapies 4/14/2021
   04/14/21 BioProcess Online Newsletter
3. 04.14.21 -- Your Drug Development Team Holds The Key To The Clinic 4/14/2021

   04/14/21 BioProcess Online Newsletter

4. 04.13.21 -- A Systematic Approach To Early Phase Sterile Tech Transfer 4/13/2021
   04/13/21 BioProcess Online Newsletter
5. 04.13.21 -- Cell & Gene Therapy Process Development Resources 4/13/2021
   04/13/21 BioProcess Online Newsletter
6. 04.12.21 -- Accelerate Viral Detection From Weeks To Days 4/12/2021
   04/12/21 BioProcess Online Newsletter
7. 04.12.21 -- Medicare Braces For Expanded Use Of High-Cost CAR T-Cell Therapy 4/12/2021

   04/12/21 BioProcess Online Newsletter

8. 04.09.21 -- Can GDF11 Address Aging, One Disease At A Time? 4/9/2021
   04/09/21 BioProcess Online Newsletter
9. 04.09.21 -- Five Common Clinical Supply Chain Speedbumps 4/9/2021
   04/09/21 BioProcess Online Newsletter
10. 04.08.21 -- How To Say Goodbye To Residual DNA 4/8/2021
    04/08/21 BioProcess Online Newsletter